Cargando…

Antidepressant Adherence Among Hispanics: Patients in an Integrated Health Care Model

PURPOSE: We report on antidepressant (AD) adherence among Hispanics seeking mental health services in a community primary care clinic in Texas as an ancillary outcome from a National Institutes of Health-funded study that collected data on Hispanic AD adherence over a period of two years (February 2...

Descripción completa

Detalles Bibliográficos
Autores principales: Kunz-Lomelin, Alan, Killian, Michael, Eghaneyan, Brittany H, Sanchez, Katherine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9809177/
https://www.ncbi.nlm.nih.gov/pubmed/36605408
http://dx.doi.org/10.2147/JMDH.S387218
_version_ 1784863069119184896
author Kunz-Lomelin, Alan
Killian, Michael
Eghaneyan, Brittany H
Sanchez, Katherine
author_facet Kunz-Lomelin, Alan
Killian, Michael
Eghaneyan, Brittany H
Sanchez, Katherine
author_sort Kunz-Lomelin, Alan
collection PubMed
description PURPOSE: We report on antidepressant (AD) adherence among Hispanics seeking mental health services in a community primary care clinic in Texas as an ancillary outcome from a National Institutes of Health-funded study that collected data on Hispanic AD adherence over a period of two years (February 2016–February 2018). Adherence to AD medications was measured throughout the year-long trial and compared across various demographic characteristics. Since Hispanic individuals often experience stigma and cultural barriers related to AD treatment, we sought to understand what factors may increase the likelihood of non-adherence in this population. PATIENTS AND METHODS: This study focused on 69 patients who were prescribed AD medications while receiving treatment through an integrated health care model. Adherence was measured with the Patient Adherence Questionnaire, a validated 2-item questionnaire that asks patients about their medication use (missed medications or dosage changes) over the past week. We looked at patient adherence at two key time points (4-weeks and 13-weeks) and utilized logistic regression to identify factors that may increase or decrease the likelihood of adherence in Hispanic patients at a community primary care clinic. RESULTS: Non-adherence to AD medication was 49.3% at 4-weeks and 57% at 13-weeks post-treatment initiation. Logistic regression analyses revealed that age was the only significant predictor of AD non-adherence. As age increased, the likelihood of adherence increased by 12.2% at 13-weeks post-treatment initiation and by 11.1% at 4-weeks post-treatment initiation. CONCLUSION: The likelihood of Hispanic patients to adhere to AD therapy increased with the age of the patient. Since primary care is the most likely place to be prescribed an AD for Hispanic patients, further research to better understand adherence is essential. Integrated health care interventions designed to help identify, reduce, or eliminate barriers to adherence and improve cultural understanding may help address issues of non-adherence in primary care settings.
format Online
Article
Text
id pubmed-9809177
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-98091772023-01-04 Antidepressant Adherence Among Hispanics: Patients in an Integrated Health Care Model Kunz-Lomelin, Alan Killian, Michael Eghaneyan, Brittany H Sanchez, Katherine J Multidiscip Healthc Original Research PURPOSE: We report on antidepressant (AD) adherence among Hispanics seeking mental health services in a community primary care clinic in Texas as an ancillary outcome from a National Institutes of Health-funded study that collected data on Hispanic AD adherence over a period of two years (February 2016–February 2018). Adherence to AD medications was measured throughout the year-long trial and compared across various demographic characteristics. Since Hispanic individuals often experience stigma and cultural barriers related to AD treatment, we sought to understand what factors may increase the likelihood of non-adherence in this population. PATIENTS AND METHODS: This study focused on 69 patients who were prescribed AD medications while receiving treatment through an integrated health care model. Adherence was measured with the Patient Adherence Questionnaire, a validated 2-item questionnaire that asks patients about their medication use (missed medications or dosage changes) over the past week. We looked at patient adherence at two key time points (4-weeks and 13-weeks) and utilized logistic regression to identify factors that may increase or decrease the likelihood of adherence in Hispanic patients at a community primary care clinic. RESULTS: Non-adherence to AD medication was 49.3% at 4-weeks and 57% at 13-weeks post-treatment initiation. Logistic regression analyses revealed that age was the only significant predictor of AD non-adherence. As age increased, the likelihood of adherence increased by 12.2% at 13-weeks post-treatment initiation and by 11.1% at 4-weeks post-treatment initiation. CONCLUSION: The likelihood of Hispanic patients to adhere to AD therapy increased with the age of the patient. Since primary care is the most likely place to be prescribed an AD for Hispanic patients, further research to better understand adherence is essential. Integrated health care interventions designed to help identify, reduce, or eliminate barriers to adherence and improve cultural understanding may help address issues of non-adherence in primary care settings. Dove 2022-12-30 /pmc/articles/PMC9809177/ /pubmed/36605408 http://dx.doi.org/10.2147/JMDH.S387218 Text en © 2022 Kunz-Lomelin et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Kunz-Lomelin, Alan
Killian, Michael
Eghaneyan, Brittany H
Sanchez, Katherine
Antidepressant Adherence Among Hispanics: Patients in an Integrated Health Care Model
title Antidepressant Adherence Among Hispanics: Patients in an Integrated Health Care Model
title_full Antidepressant Adherence Among Hispanics: Patients in an Integrated Health Care Model
title_fullStr Antidepressant Adherence Among Hispanics: Patients in an Integrated Health Care Model
title_full_unstemmed Antidepressant Adherence Among Hispanics: Patients in an Integrated Health Care Model
title_short Antidepressant Adherence Among Hispanics: Patients in an Integrated Health Care Model
title_sort antidepressant adherence among hispanics: patients in an integrated health care model
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9809177/
https://www.ncbi.nlm.nih.gov/pubmed/36605408
http://dx.doi.org/10.2147/JMDH.S387218
work_keys_str_mv AT kunzlomelinalan antidepressantadherenceamonghispanicspatientsinanintegratedhealthcaremodel
AT killianmichael antidepressantadherenceamonghispanicspatientsinanintegratedhealthcaremodel
AT eghaneyanbrittanyh antidepressantadherenceamonghispanicspatientsinanintegratedhealthcaremodel
AT sanchezkatherine antidepressantadherenceamonghispanicspatientsinanintegratedhealthcaremodel